Abeona Therapeutics (ABEO) Other Operating Expenses (2011 - 2026)

Abeona Therapeutics' Other Operating Expenses history runs 15 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $6.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.4 million, changed N/A from the prior year.
• Other Operating Expenses eased to $2.7 million in Q1 2026 per ABEO's latest filing, from $2.8 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $2.8 million in Q4 2025 and bottomed at -$1.1 million in Q2 2022.
• The 4-year median for Other Operating Expenses is $277000.0 (2022), against an average of $564181.8.
• Across the five-year window, Other Operating Expenses plunged 733.33% in 2022 and soared 6816.67% in 2023, its largest moves.
• Year by year, Other Operating Expenses stood at $277000.0 in 2022, then tumbled by 89.17% to $30000.0 in 2023, then soared by 9356.67% to $2.8 million in 2025, then fell by 4.97% to $2.7 million in 2026.
• Per Business Quant, the three latest ABEO Other Operating Expenses figures stand at $2.7 million (Q1 2026), $2.8 million (Q4 2025), and $488000.0 (Q3 2025).